We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Vaccine Prevents Growth of Colorectal Tumors Related to Lynch Syndrome in Mice
Friday, April 19, 2019
Steven Lipkin, M.D., Ph.D., Co-Leader of the Meyer Cancer Center's Cancer Genetics, Epigenetics, and Systems Biology Program, reported results of a cancer prevention vaccine at the American Association for Cancer Research 2019 Annual Meeting. The vaccine prevented the growth of colorectal tumors in a mouse model of Lynch syndrome and prolonged the mice’s survival compared with unvaccinated mice.
“The simplicity of this approach means that it is promising to take forward” to a human vaccine, Dr. Lipkin said during a press briefing April 1 at the AACR's annual meeting in Atlanta. Read more about the exciting results of this study funded by the National Cancer Institute on their Cancer Currents Blog.